Search Medical Condition
Please enter condition
Please choose location
 

Rincon, Georgia Clinical Trials

A listing of Rincon, Georgia clinical trials actively recruiting patient volunteers.

RESULTS

Found (6) clinical trials

Efficacy and Safety of Glycopyrronium/Formoterol Fumarate Fixed-dose Combination Relative to Umeclidinium/Vilanterol Fixed-dose Combination Over 24 Weeks in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

This is a phase IIIb randomised, double-blind, double-dummy, multicentre, parallel group, 24 week study to assess the efficacy and safety of Glycopyrronium/Formoterol Fumarate (GFF) fixed-dose combination 7.2/4.8 μg 2 inhalations twice daily compared to Umeclidinium/Vilanterol (UV) 62.5/25 μg fixed-dose combination 1 inhalation once daily in Patients with moderate to very ...

Phase

0.0 miles

Learn More »

You are being asked to participate in this research study because you have moderate to very severe Chronic Obstructive Pulmonary Disease or COPD and a history of COPD exacerbations. The purpose of this study is to assess the effects of BGF MDI, GFF MDI and BFF MDI on the rate ...

Phase

0.0 miles

Learn More »

This is a research study to test investigational drugs for which Pearl Therapeutics plans to seek marketing approval from the U.S. Food and Drug Administration (FDA) and Regulatory Authorities in other countries. The purpose of this study is to: Evaluate the effect of BGF MDI, GFF MDI, and BFF MDI ...

Phase

0.0 miles

Learn More »

We will examine whether or not lebrikizumab improves lung function in people with COPD. We also hope to learn whether lebrikizumab reduces the number of COPD exacerbations and improves symptoms in people who do not have good control of their COPD despite being treated with a long-acting bronchodilator and an ...

Phase

0.0 miles

Learn More »

The purpose of this study is to measure the effectiveness and safety of TD-4208, a drug being developed for people with moderate to very severe COPD, compared to a drug called tiotropium.

Phase N/A

0.0 miles

Learn More »

This is a research study to test investigational drugs for which Pearl Therapeutics plans to seek marketing approval from the U.S. Food and Drug Administration (FDA) and Regulatory Authorities in other countries. The purpose of this study is to: Assess the effects of BGF MDI, GFF MDI, BFF MDI, and ...

Phase

0.0 miles

Learn More »